Microbiotica Announced as a Finalist in ‘Best Emerging Biotech Company’ Category at OBN Awards 2020

/in /by

Cambridge, UK, 9 September 2020 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, been selected as a finalist in the ‘Best Emerging Biotech Company’ category at the OBN Awards 2020. The winners will be announced on Thursday 26th November.

Microbiotica has established itself as a leading global player in its field, and most recently it has been recognised for its collaboration with Cancer Research UK and CUH. This has so far allowed the company to discover the first gut bacterial signature predictive of drug response of immuno-oncology checkpoint inhibitors which it is developing as a potentially transformational medicine to convert non-responding patients to responders. This collaboration is a further validation of the Company’s technology following a major collaboration with Genentech/Roche in Inflammatory Bowel Disease (IBD), and one with University of Adelaide to develop novel bacterial therapy for Ulcerative Colitis.

The OBN Awards, now in their 12th year, celebrate outstanding achievement throughout the life sciences industry. The awards seek to shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches, outstanding company progression, fresh thinking around collaborations and deal-making as well as the critical role that support organisations play in helping the life sciences industry thrive.

Dr Mike Romanos, CEO of Microbiotica, said: “The OBN awards are one of our industry’s most prestigious awards as judged by a panel of leading industry entrepreneurs and experts. We are delighted to receive the industry-wide recognition that being shortlisted for Best Emerging Biotech Company brings. This is testament to the outstanding achievements made by Microbiotica in its four years of existence.”

Details of the awards ceremony are as follows:

OBN Awards 2020
Date: 26 November 2020
Venue: The Royal Lancaster Hotel, London
For more information, see here: https://obn-awards.com/